Risk of Arterial and Venous Thromboembolic Events with Bevacizumab, an Antibody against Vascular Endothelial Growth Factor A (VEGF-A): A Systematic Review and Meta-Analysis. GJMR [Internet]. 2020 Feb. 22 [cited 2026 Aug. 13];20(B1):71-85. Available from: https://medicalresearchjournal.org/index.php/GJMR/article/view/1952